Literature DB >> 11986278

Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins.

P H M Leung1, J S M Peiris, W W S Ng, W C Yam.   

Abstract

The A1 subunits of verotoxin-1 (VT1) and VT2 genes were cloned into pGEX-4T-2 for the expression of glutathione S-transferase (GST) fusion proteins. The N-terminal and the transmembrane regions of the A1 subunits were excluded from the constructs in order to increase the product yields. Polyclonal anti-VT1A1 and anti-VT2A1 antibodies were produced by immunizing rabbits with GST-VT1A1 and GST-VT2A1 fusion proteins, respectively. The antibodies were tested for their ability to neutralize active toxins from 45 VT-producing Escherichia coli (VTEC) strains. The antibodies had significantly high neutralizing activities against their homologous toxins. The average percentages of neutralization of VT1 by anti-GST-VT1A1 and anti-GST-VT2A1 were 76.7% +/- 7.9% and 3.6% +/- 2.3%, respectively, and those of VT2 were 1.7% +/- 2.3% and 82.5% +/- 13.9%, respectively. VT2 variant toxin was neutralized by anti-GST-VT2A1, with cross neutralization being a possible consequence of sequence homology between VT2 and a VT2 variant. To our knowledge, this is the first report on the production of polyclonal antibodies from GST-VT fusion proteins. The antibodies were shown to exhibit specific toxin neutralizing activities and may be useful for immunological diagnosis of VTEC infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986278      PMCID: PMC120006          DOI: 10.1128/cdli.9.3.687-692.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

1.  A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.

Authors:  S B Calderwood; D W Acheson; M B Goldberg; S A Boyko; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.

Authors:  S K Saxena; A D O'Brien; E J Ackerman
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

3.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity.

Authors:  H Nakao; N Kiyokawa; J Fujimoto; S Yamasaki; T Takeda
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Prediction of transmembrane segments in proteins utilising multiple sequence alignments.

Authors:  B Persson; P Argos
Journal:  J Mol Biol       Date:  1994-03-25       Impact factor: 5.469

Review 6.  Verocytotoxins (Shiga-like toxins) produced by Escherichia coli: a minireview of their classification, clinical presentations and management of a heterogeneous family of cytotoxins.

Authors:  D Agbodaze
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1999-10       Impact factor: 2.268

7.  Minimum domain of the Shiga toxin A subunit required for enzymatic activity.

Authors:  J E Haddad; A Y al-Jaufy; M P Jackson
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

8.  Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology.

Authors:  F Gunzer; H Karch
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

10.  Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511.

Authors:  C K Schmitt; M L McKee; A D O'Brien
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more
  1 in total

1.  A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli.

Authors:  P H M Leung; J S M Peiris; W W S Ng; R M Robins-Browne; K A Bettelheim; W C Yam
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.